Ignite Creation Date:
2025-12-26 @ 1:19 PM
Ignite Modification Date:
2026-01-15 @ 12:54 PM
Study NCT ID:
NCT00043706
Status:
COMPLETED
Last Update Posted:
2015-03-05
First Post:
2002-08-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis
Sponsor:
Genzyme, a Sanofi Company
Organization: